divendres, 24 d’octubre del 2014

Novo Nordisk receives U.S. subpoena related to Danish factory




The U.S. attorney for Massachusetts subpoenas Novo Nordisk for documents on its plant in Denmark that makes half the world's supply of insulin.






(Reuters) - Denmark's Novo Nordisk , the world's biggest maker of insulin, has received a U.S. subpoena requesting documents relating to potential manufacturing issues at its Kalundborg plant in Denmark, the company said on Friday.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://www.massdevice.com/news/novo-nordisk-receives-us-subpoena-related-danish-factory

Sinopsys Surgical gains $8.3M funding round for sinusitis device | Medtech funding for the week of October 20, 2014




Here's a look at some of the top legal news stories for medical device companies this week: Sinopsys Surgical sniffs up $8.3m for sinusitis device; ZipLine Medical adds $5.7m to Series C round; Medrobotics taps backers for $20m; Sensory Medical raises $1.4m for Relaxis restless legs treatment; Stealth hypertension startup Sympara Medical raises nearly $6m






Sinopsys Surgical sniffs up $8.3m for sinusitis device


October 17, 2014 by Alexander Soule




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oBO87c

Report: EndoStim tables IPO




EndoStim, which makes an implantable device to treat gastroesophageal reflux disease, reportedly tables its initial public offering due to poor market conditions.






EndoStim, citing poor market conditions, has tabled its initial public offering it hoped would raise nearly $36 million for its neurostimulation device for gastroesophageal reflux disease, according to Renaissance Capital.


EndoStim had planned to put $10 million of the IPO's proceeds into clinical studies and another $14 million to commercialize the system.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vYHuZw

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pushing the envelope




In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.







Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pushing the envelope



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tQJXX9

dijous, 23 d’octubre del 2014

BREAKING: Jury clears DePuy in 1st Pinnacle bellwether trial




A federal jury in Texas reportedly clears Johnson & Johnson's DePuy Pinnacle hip implant in the 1st bellwether product liability trial over the metal-on-metal device.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1wgJDRH

Edwards Lifesciences posts double-digit Q3 sales, earnings increases




Edwards Lifesciences reports 3rd-quarter sales and earnings growth in excess of 20% and raises its outlook for the rest of the year.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1z1UrEc

Japanese elder care market: 4 key medical device segments




Insights and updates from the experts at Pacific Bridge Medical (PBM). PBM's blog provides recent medical device and pharmaceutical business trends and regulatory updates in Asia.





Q&A on Japan's mixed medical treatment reforms

By Ames Gross, President, Pacific Bridge Medical




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xemlbK